Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2151796> ?p ?o }
Showing triples 1 to 48 of
48
with 100 triples per page.
- Q2151796 subject Q7211328.
- Q2151796 subject Q8593033.
- Q2151796 abstract "Ridaforolimus (also known as AP23573 and MK-8669; formerly known as Deforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy. Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism, and angiogenesis.It has had promising results in a clinical trial for advanced soft tissue and bone sarcoma.".
- Q2151796 atcPrefix "L01".
- Q2151796 atcSuffix "XE19".
- Q2151796 casNumber "572924-54-0".
- Q2151796 chEBI "82677".
- Q2151796 fdaUniiCode "48Z35KB15K".
- Q2151796 iupacName "(1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28Z,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl dimethylphosphinate".
- Q2151796 pubchem "11520894".
- Q2151796 thumbnail Deforolimus.svg?width=300.
- Q2151796 wikiPageExternalLink www.ariad.com.
- Q2151796 wikiPageWikiLink Q1057.
- Q2151796 wikiPageWikiLink Q1340863.
- Q2151796 wikiPageWikiLink Q1368197.
- Q2151796 wikiPageWikiLink Q14876086.
- Q2151796 wikiPageWikiLink Q14878377.
- Q2151796 wikiPageWikiLink Q17.
- Q2151796 wikiPageWikiLink Q188909.
- Q2151796 wikiPageWikiLink Q189159.
- Q2151796 wikiPageWikiLink Q2112244.
- Q2151796 wikiPageWikiLink Q223911.
- Q2151796 wikiPageWikiLink Q247489.
- Q2151796 wikiPageWikiLink Q423650.
- Q2151796 wikiPageWikiLink Q423725.
- Q2151796 wikiPageWikiLink Q4653724.
- Q2151796 wikiPageWikiLink Q5282002.
- Q2151796 wikiPageWikiLink Q539568.
- Q2151796 wikiPageWikiLink Q5425274.
- Q2151796 wikiPageWikiLink Q608510.
- Q2151796 wikiPageWikiLink Q7211328.
- Q2151796 wikiPageWikiLink Q8593033.
- Q2151796 wikiPageWikiLink Q974135.
- Q2151796 atcPrefix "L01".
- Q2151796 atcSuffix "XE19".
- Q2151796 casNumber "572924".
- Q2151796 chebi "82677".
- Q2151796 iupacName "-4".
- Q2151796 pubchem "11520894".
- Q2151796 unii "48".
- Q2151796 type ChemicalSubstance.
- Q2151796 type Drug.
- Q2151796 type ChemicalObject.
- Q2151796 type Thing.
- Q2151796 type Q8386.
- Q2151796 comment "Ridaforolimus (also known as AP23573 and MK-8669; formerly known as Deforolimus) is an investigational targeted and small-molecule inhibitor of the protein mTOR, a protein that acts as a central regulator of protein synthesis, cell proliferation, cell cycle progression and cell survival, integrating signals from proteins, such as PI3K, AKT and PTEN known to be important to malignancy.".
- Q2151796 label "Ridaforolimus".
- Q2151796 depiction Deforolimus.svg.